DORTMUND, Germany & VANCOUVER, British Columbia--(BUSINESS WIRE)--The Centre for Drug Research and Development (CDRD) and the Lead Discovery Center GmbH (LDC), two leading drug discovery and development centres supporting the commercialization of research from academic institutions across Canada, from select global partners, and from Germany’s Max Planck Institutes, today announced they have signed a Partnership Agreement to enable joint development of promising innovations from their broad networks. The agreement includes sharing infrastructure and expertise from LDC’s and CDRD’s powerful drug development platforms in order to support the organizations’ shared objective of successfully translating basic research into high-quality commercial opportunities – and ultimately into new medicines that will benefit patients around the world.
